News
ZIOPHARM Oncology and Solasia Pharma Announce Global License and...
www.globenewswire.com
Jul 31, · ... from the acquisition of exclusive global development and commercialization rights to darinaparsin from ZIOPHARM," said Yoshihiro Arai, ...
Alcami, Solasia Enter API Mfg. Pact - Contract Pharmawww.contractpharma.com › contents › view_breaking-news
www.contractpharma.com
"We are pleased to entrust Alcami with this project," said Mr. Yoshihiro Arai, president and chief executive officer of Solasia Pharma, K.K. ...
Japanese tourists shot dead in Philippines, bodies cut into pieces...
www.ibtimes.co.uk
The Philippines coast guard said three men have confessed to the crime.
Isofol enters licensing agreem - GuruFocus.com
www.gurufocus.com
... Japan," said Yoshihiro Arai, President & CEO of Solasia. Isofol's drug candidate arfolitixorin is being evaluated in the ongoing global Phase
sorted by relevance / date